8 completed, 1 terminated, 1 unknown. 8 Phase 1, 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 8 |
| Phase 2 | 5 | Completed 4, Terminated 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Triferic: new trials by email Literature Review of Triferic trials Research Report on Triferic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC) Triferic - End Stage Renal Disease | Phase 3 | Unknown | Rockwell Medical Technologies, Inc. | 150 | 2020-09-01 | 2021-04-21 |
| Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus. Triferic - End Stage Renal Disease | Phase 1 / Phase 2 | Completed | Rockwell Medical Technologies, Inc. | 23 | 2020-06-25 | 2021-07-13 |
| A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients Triferic, Heparin - End Stage Renal Disease | Phase 1 / Phase 2 | Completed | Rockwell Medical Technologies, Inc. | 12 | 2019-09-30 | 2020-12-02 |
| Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients Triferic - End Stage Renal Disease | Phase 1 / Phase 2 | Completed | Rockwell Medical Technologies, Inc. | 27 | 2017-10-01 | 2020-11-16 |
| Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol Fer-In-Sol, Shohl's solution, Triferic - Iron-Refractory Iron-Deficiency Anemia | Phase 2 | Terminated | Rockwell Medical Technologies, Inc. | 1 | 2017-01-17 | 2020-09-22 |
| Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis Triferic - Peritoneal Dialysis (PD), Anemia | Phase 1 | Completed | Rockwell Medical Technologies, Inc. | 30 | 2017-01-01 | 2019-08-08 |
| Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers Triferic, Fer-In-Sol, Shohl's solution - Iron-refractory, Iron-deficiency Anemia (IRIDA) | Phase 1 | Completed | Rockwell Medical Technologies, Inc. | 14 | 2016-04-01 | 2019-02-01 |
| Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients Triferic - End Stage Renal Disease | Phase 1 | Completed | Rockwell Medical Technologies, Inc. | 13 | 2016-04-01 | 2019-02-01 |
| Triferic Pediatric Pharmacokinetic Protocol Triferic - End Stage Renal Disease | Phase 1 / Phase 2 | Completed | Rockwell Medical Technologies, Inc. | 22 | 2015-11-01 | 2018-10-25 |
| Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers Triferic - End Stage Renal Disease | Phase 1 | Completed | Rockwell Medical Technologies, Inc. | 12 | 2015-10-01 | 2019-08-20 |
Kidney Failure, Chronic (7) · Renal Insufficiency, Chronic (3) · Anemia (2) · Iron-Refractory Iron Deficiency Anemia (2)
Rockwell Medical Technologies, Inc. (10)
United States (8) · Puerto Rico (1)
Raymond D Pratt, MD, FACP (4) · Raymond D Pratt, MD FACP (3) · Raymond Pratt, MD (1) · Thomas Marbury (1)